At the forefront of therapies for rare and orphan diseasesTM
HOME CONTACT US         
Share
about us| programs| science & technology | patient advocacy | clinical studies | investors | collaborations | news & events
 
Investors
 



Home >> Investor Relations >> Corporate Governance >> Insider Transactions

Insider Transactions

Date Name Sorted Descending Title Type Shares Traded Price Range
Nov 18, 2008 bloch stephen m Director Automatic Sell 3,000 9.11
Nov 17, 2008 bloch stephen m Director Automatic Sell 7,740 9.02
Nov 14, 2008 bloch stephen m Director Automatic Sell 3,800 9.34
Nov 13, 2008 bloch stephen m Director Automatic Sell 3,000 9.41
Nov 12, 2008 bloch stephen m Director Automatic Sell 3,000 9.58
Nov 11, 2008 bloch stephen m Director Automatic Sell 3,000 9.20
Nov 10, 2008 bloch stephen m Director Automatic Sell 3,000 8.98
Nov 7, 2008 bloch stephen m Director Automatic Sell 3,000 9.08
Nov 6, 2008 bloch stephen m Director Automatic Sell 3,000 9.24
Nov 5, 2008 bloch stephen m Director Automatic Sell 3,900 10.04
Nov 4, 2008 bloch stephen m Director Automatic Sell 3,800 10.54
Nov 3, 2008 bloch stephen m Director Automatic Sell 3,000 10.24
Oct 31, 2008 bloch stephen m Director Automatic Sell 3,000 9.85
Oct 30, 2008 bloch stephen m Director Automatic Sell 3,000 9.54
Oct 29, 2008 bloch stephen m Director Automatic Sell 3,000 8.51
Oct 28, 2008 bloch stephen m Director Automatic Sell 2,601 8.50
Oct 27, 2008 bloch stephen m Director Automatic Sell 2,942 8.89
Oct 24, 2008 bloch stephen m Director Automatic Sell 3,000 9.70
Oct 23, 2008 bloch stephen m Director Automatic Sell 3,000 9.76
Oct 22, 2008 bloch stephen m Director Automatic Sell 3,000 10.48
Showing 301-320 of 392 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Amicus Therapeutics, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.


Copyright © 2012 Amicus Therapeutics, Inc. All rights reserved.   Terms of Use | Privacy Policy